ANDEMBRY
Active substance: garadacimab
INJECTION, SOLUTION · GARADACIMAB 200 mg/1.2mL
United StatesActive
Marketing holder: CSL
Verified 2026-10-09 · openFDA NDC
- Source: openFDA NDC
Composition
- GARADACIMAB · 200 mg/1.2mL
Registration
- Registration number
- 63833-925
- Registration status
- Active
- Dispensing
- Prescription only
- Route
- SUBCUTANEOUS
Sources
- product · openFDA NDC · 63833-925 · Verified 2026-10-09 · open in source
- registration_status · openFDA NDC · 63833-925 · Verified 2026-10-09 · open in source
- ingredients.0 · openFDA NDC · 63833-925 · Verified 2026-10-09 · open in source